Japanese firm Dainippon Sumitomo Pharma Co Ltd (4506.T) agrees a $2.7 billion to buy Sepracor Inc (SEPR.O). Dainippon will acquire a 1,000-strong sales force and drugs to treat insomnia and epilepsy from U.S.-based Sepracor.
Thermo Fisher Scientific (TMO.N) has agreed a 330 million euro purchase of German firm Brahms, a manufacturer of disease diagnosis tests. Thermo Fisher, which makes scientific instruments, said the deal would open up promising opportunities for commercialising new patents.
For more on this and the latest Reuters deals news, click here.
And here’s a round-up of deal-related stories from Thursday’s press:
* The UK market regulator, the FSA, is stress-testing plans by banking group Lloyds (LLOY.L) to raise 10 billion pounds ($16.17 billion) and reduce its dependence on a state-backed toxic debt insurance scheme, the Daily Telegraph reported.